Please provide your email address to receive an email when new articles are posted on . The FDA cleared the investigational new drug application for ExeGi Pharma LLC’s, EXE-346, a live biotherapeutic ...

Ileoanal pouch failure is the need for permanent diversion and/or pouchectomy and/or redoing a J-pouch and occurs in 9% to 12% of patients. The most common cause of pouch failure in the studies ...

Inflammation that occurs after J-pouch surgery is a common complication of the procedure. Here’s advice on how to cope. Christine Lenhardt was seven months pregnant with her second child when she ...

"The early identification of patients at risk for the development of pouchitis remains an unmet need given that patients developing pouchitis in the first year after IPAA have demonstrated an ...